2023-507721-41-00已完成1 期
A trial of prednisolone in combination with SPI-62 in participants with polymyalgia rheumatica (PMR)
Sparrow Pharmaceuticals Inc.5 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2024年2月20日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 14
- 试验地点
- 5
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Scientific contact point
Scientific
Sparrow Pharmaceuticals Inc.
研究点 (5)
Loading locations...
相似试验
招募中
1 期
A study to investigate whether application of SPI-62 necessitates an increase of the prednisolone dose to maintain the same efficacy of treatment of polymyalgia rheumaticapolymyalgia rheumaticaEUCTR2022-000299-20-PLSparrow Pharmaceuticals, Inc.48
招募中
1 期
A study to investigate whether application of SPI-62 necessitates an increase of the prednisolone dose to maintain the same efficacy of treatment of polymyalgia rheumaticaMedDRA version: 21.0Level: PTClassification code 10036099Term: Polymyalgia rheumaticaSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorderspolymyalgia rheumaticaEUCTR2022-000299-20-DESparrow Pharmaceuticals, Inc.72
已完成
2 期
A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)Polymyalgia RheumaticaNCT05436652Sparrow Pharmaceuticals66
已完成
2 期
Effect of dapson in treatment of pemphigus vulgarisPemphigus vulgaris.Pemphigus vulgarisIRCT201307133566N2Tabriz university of medical sciences, assistance research30
终止
1 期
A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR)Polymyalgia RheumaticaNCT06281236Sparrow Pharmaceuticals1